Silo Pharma (SILO) Enterprise Value (2019 - 2025)
Silo Pharma (SILO) has disclosed Enterprise Value for 7 consecutive years, with -$6.9 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 3.13% to -$6.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.9 million through Dec 2025, up 3.13% year-over-year, with the annual reading at -$6.9 million for FY2025, 3.13% up from the prior year.
- Enterprise Value hit -$6.9 million in Q4 2025 for Silo Pharma, down from -$5.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$4.2 million in Q2 2021 to a low of -$12.3 million in Q3 2022.
- Historically, Enterprise Value has averaged -$8.1 million across 5 years, with a median of -$7.8 million in 2023.
- Biggest five-year swings in Enterprise Value: crashed 50611.35% in 2021 and later skyrocketed 36.85% in 2024.
- Year by year, Enterprise Value stood at -$10.3 million in 2021, then fell by 10.85% to -$11.4 million in 2022, then surged by 32.58% to -$7.7 million in 2023, then rose by 7.63% to -$7.1 million in 2024, then rose by 3.13% to -$6.9 million in 2025.
- Business Quant data shows Enterprise Value for SILO at -$6.9 million in Q4 2025, -$5.9 million in Q3 2025, and -$6.3 million in Q2 2025.